New Millennium Group’s Edwards Lifesciences EW Stock Holding History

New Millennium Group’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	$597	Hold	7	–	–	﹤0.01%	352
2025 Q3	$544	Hold	7	–	–	﹤0.01%	383
2025 Q2	$547	Hold	7	–	–	﹤0.01%	377
2025 Q1	$507	Hold	7	–	–	﹤0.01%	424
2024 Q4	$518	Hold	7	–	–	﹤0.01%	526
2024 Q3	$462	Hold	7	–	–	﹤0.01%	370
2024 Q2	$647	Buy	+7	New	+$620	﹤0.01%	365
2024 Q1	–	Sell	-172	Closed	-$13.1K	–	172
2023 Q4	$13.1K	Hold	172	–	–	0.01%	182
2023 Q3	$11.9K	Sell	172 -217	-56%	-$17.4K	0.01%	161
2023 Q2	$36.7K	Sell	389 -168	-30%	-$14.6K	0.03%	103
2023 Q1	$46.1K	Sell	557 -1	-0.2%	-$79	0.05%	106
2022 Q4	$41.6K	Sell	558 -5	-0.9%	-$385	0.04%	104
2022 Q3	$47K	Sell	563 -2	-0.4%	-$192	0.05%	96
2022 Q2	$54K	Buy	+565	New	+$58.5K	0.06%	96

Other funds holding EW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

New Millennium Group's EW Position: Q4 2025 in Review

New Millennium Group held its Edwards Lifesciences (EW) position steady in Q4 2025 at 7 shares worth $597. The position accounts for ﹤0.01% of the portfolio, ranked #352.

New Millennium Group first reported a position in EW in Q2 2022 and has held it in 14 quarters since. The position peaked at $54K in Q2 2022. 1,313 funds tracked by Wall St. Rank hold EW as of Q4 2025.

New Millennium Group held 7 shares of Edwards Lifesciences worth $597 as of Q4 2025.
New Millennium Group left its Edwards Lifesciences share count unchanged in Q4 2025.
Edwards Lifesciences made up ﹤0.01% of New Millennium Group's portfolio in Q4 2025, its #352 holding.
New Millennium Group first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 14 quarters since.
New Millennium Group's Edwards Lifesciences position peaked at $54K in Q2 2022.
1,313 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2025.

Based on New Millennium Group's 13F filing for Q4 2025, filed 6 Feb 2026.